nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addressing the rise of early-onset colorectal cancer
|
The Lancet Gastroenterology & Hepatology, |
|
|
7 |
3 |
p. 197 |
artikel |
2 |
Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial
|
Meng, Xiangrui |
|
|
7 |
3 |
p. 245-253 |
artikel |
3 |
Correction to Lancet Gastroenterol Hepatol 2021; 6: 569–77
|
|
|
|
7 |
3 |
p. e7 |
artikel |
4 |
Deep neural network for video colonoscopy of ulcerative colitis: a cross-sectional study
|
Takenaka, Kento |
|
|
7 |
3 |
p. 230-237 |
artikel |
5 |
Emerging evidence for VEGF and immune checkpoint inhibition in oesophagogastric cancer
|
Ilson, David H |
|
|
7 |
3 |
p. 200-201 |
artikel |
6 |
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases
|
Guillo, Lucas |
|
|
7 |
3 |
p. 254-261 |
artikel |
7 |
ESWL pancreatitis: yet another post-procedural pancreatitis to worry about?
|
Aabakken, Lars |
|
|
7 |
3 |
p. 199-200 |
artikel |
8 |
Exploring novel avenues for neoadjuvant treatment of hepatocellular carcinoma
|
Personeni, Nicola |
|
|
7 |
3 |
p. 198-199 |
artikel |
9 |
Let's talk toilets
|
Zajanckauskaite, Estera |
|
|
7 |
3 |
p. 206 |
artikel |
10 |
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
|
Marron, Thomas U |
|
|
7 |
3 |
p. 219-229 |
artikel |
11 |
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
|
Kaseb, Ahmed Omar |
|
|
7 |
3 |
p. 208-218 |
artikel |
12 |
Rectal indometacin to prevent pancreatitis after extracorporeal shock wave lithotripsy (RIPEP): a single-centre, double-blind, randomised, placebo-controlled trial
|
Qian, Yang-Yang |
|
|
7 |
3 |
p. 238-244 |
artikel |
13 |
Research in Brief
|
Baker, Holly |
|
|
7 |
3 |
p. 205 |
artikel |
14 |
Seeing C diff differently
|
Stephenson, Amber L |
|
|
7 |
3 |
p. 207 |
artikel |
15 |
Thank you to The Lancet Gastroenterology & Hepatology's clinical and statistical peer reviewers in 2021
|
|
|
|
7 |
3 |
p. e3-e6 |
artikel |
16 |
The need for a reliable non-invasive diagnostic biomarker for eosinophilic oesophagitis
|
Rossi, Carlo Maria |
|
|
7 |
3 |
p. 202-203 |
artikel |
17 |
The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection
|
Patel, Swati G |
|
|
7 |
3 |
p. 262-274 |
artikel |
18 |
Towards health equity: the urgent need for upstream intervention studies in gastroenterology and hepatology
|
Liu, Joy J |
|
|
7 |
3 |
p. 203-204 |
artikel |